1

2

VolumeDriven Health Care

Value Driven Health Care

3

Over 2,400 pages of the final ruling, released October 14th, 2016

4

Baseline (budget neutral)

202020192017

-4% -5% -7% -9%

2018

5

Your data is public

Report for a partial year

90 days

Report“some data”

(from certain categories)

Full year of reportingathena Clients

TRACKTWO

TRACKTHREE

TRACKONE

2017 – “pick your reporting pace” year

7

8

9

Let’s geek out

10

4 MIPS Reporting Categories

Quality

Cost

Care Coordination(Improvement Activities)

EHR Use(Advancing Care Information)

Quality – Measuring the standard of care provided to your patients

12

Each individual measure worth up to 10 points

QualityMeasure

High PriorityMeasure

Outcomes Measure

Quality Measure

Quality Measure

Quality Measure

20 case minimum for all

measures6 reported measures

At least one must be an Outcome Measure

ORa High Priority

Measure

13

13 clinician practice

Points Earned(performance weighted)

6 Selected Measures

5.1

9.3

6

7.3

8.5

3

Bonus Points

Quality points

subtotal=

39.2

Quality points total

=43.2

(out of possible 60)

1

1

1

1

Dr. Samuel Optimal Asthma Control

Childhood Immunization Status

Tobacco Use: Screening and

Cessation Intervention

Breast Cancer Screening

Falls: Risk Assessment

Use of Imaging Studies for Low Back Pain

CEHRT

CEHRT

CEHRT

High Priority

14

Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy - Avoidance of Inappropriate UseAcute Otitis Externa (AOE): Topical TherapyADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) MedicationAdherence to Antipsychotic Medications For Individuals with SchizophreniaAdult Kidney Disease: Blood Pressure ManagementAdult Kidney Disease: Catheter Use at Initiation of HemodialysisAdult Kidney Disease: Catheter Use for Greater Than or Equal to 90 DaysAdult Kidney Disease: Referral to HospiceAdult Major Depressive Disorder (MDD): Coordination of Care of Patients with Specific Comorbid ConditionsAdult Major Depressive Disorder (MDD): Suicide Risk AssessmentAdult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of SurgeryAdult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of SurgeryAdult Sinusitis: Antibiotic Prescribed for Acute Sinusitis (Overuse)Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use)Adult Sinusitis: Computerized Tomography (CT) for Acute Sinusitis (Overuse)Adult Sinusitis: More than One Computerized Tomography (CT) Scan Within 90 Days for Chronic Sinusitis (Overuse)Age Appropriate Screening ColonoscopyAge-Related Macular Degeneration (AMD): Counseling on Antioxidant SupplementAge-Related Macular Degeneration (AMD): Dilated Macular ExaminationAll-cause Hospital ReadmissionAmyotrophic Lateral Sclerosis (ALS) Patient Care PreferencesAnastomotic Leak InterventionAnesthesiology Smoking AbstinenceAnnual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug UsersAnti-Depressant Medication ManagementAppropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for RemovalAppropriate Follow-up Imaging for Incidental Abdominal LesionsAppropriate Follow-up Imaging for Incidental Thyroid Nodules in PatientsAppropriate Follow-Up Interval for Normal Colonoscopy in Average Risk PatientsAppropriate Testing for Children with PharyngitisAppropriate Treatment for Children with Upper Respiratory Infection (URI)Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) BacteremiaAppropriate Workup Prior to Endometrial AblationAtrial Fibrillation and Atrial Flutter: Chronic Anticoagulation TherapyAvoidance of Antibiotic Treatment in Adults With Acute BronchitisBarrett's EsophagusBasal Cell Carcinoma (BCC)/Squamous Cell Carcinoma: Biopsy Reporting Time - Pathologist to ClinicianBiopsy Follow-UpBipolar Disorder and Major Depression: Appraisal for alcohol or chemical substance useBreast Cancer Resection Pathology Reporting: pT Category (Primary Tumor) and pN Category (Regional Lymph Nodes) with Histologic GradeBreast Cancer ScreeningCAHPS for PQRS Clinician/Group SurveyCardiac Rehabilitation Patient Referral from an Outpatient SettingCardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery PatientsCardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI)Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk PatientsCare PlanCataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract SurgeryCataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical ProceduresCataracts: Improvement in Patient's Visual Function within 90 Days Following Cataract SurgeryCataracts: Patient Satisfaction within 90 Days Following Cataract SurgeryCataract Surgery: Difference Between Planned and Final RefractionCataract Surgery with Intra-Operative Complications (Unplanned Rupture of Posterior Capsule Requiring Unplanned Vitrectomy)Cervical Cancer ScreeningChild and Adolescent Major Depressive Disorder (MDD): Suicide Risk AssessmentChildhood Immunization StatusChildren Who Have Dental Decay or CavitiesChlamydia Screening and Follow UpChlamydia Screening for WomenChronic Obstructive Pulmonary Disease (COPD): Long-Acting Inhaled Bronchodilator TherapyChronic Obstructive Pulmonary Disease (COPD): Spirometry EvaluationClinical Outcome Post Endovascular Stroke TreatmentClosing the Referral Loop: Receipt of Specialist ReportColonoscopy Interval for Patients with a History of Adenomatous Polyps - Avoidance of Inappropriate UseColorectal Cancer Resection Pathology Reporting: pT Category (Primary Tumor) and pN Category (Regional Lymph Nodes) with Histologic GradeColorectal Cancer ScreeningCommunication with the Physician or Other Clinician Managing On-going Care Post-Fracture for Men and Women Aged 50 Years and OlderControlling High Blood PressureCoronary Artery Bypass Graft (CABG): Deep Sternal Wound Infection RateCoronary Artery Bypass Graft (CABG): Postoperative Renal FailureCoronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG SurgeryCoronary Artery Bypass Graft (CABG): Prolonged IntubationCoronary Artery Bypass Graft (CABG): StrokeCoronary Artery Bypass Graft (CABG): Surgical Re-ExplorationCoronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Patients with Isolated CABG SurgeryCoronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy -Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)Coronary Artery Disease (CAD): Antiplatelet TherapyCoronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)Dementia: Caregiver Education and SupportDementia: Cognitive AssessmentDementia: Counseling Regarding Safety ConcernsDementia: Functional Status AssessmentDementia: Management of Neuropsychiatric SymptomsDementia: Neuropsychiatric Symptom AssessmentDepression Remission at Six MonthsDepression Remission at Twelve MonthsDepression Utilization of the PHQ-9 ToolDiabetes: Eye ExamDiabetes: Foot ExamDiabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)Diabetes: Medical Attention for NephropathyDiabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy - Neurological EvaluationDiabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention - Evaluation of Footwear

Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes CareDiabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of RetinopathyDocumentation of Current Medications in the Medical RecordDocumentation of Signed Opioid Treatment AgreementDoor to Puncture Time for Endovascular Stroke TreatmentElder Maltreatment Screen and Follow-Up PlanEmergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and OlderEmergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 YearsEpilepsy: Counseling for Women of Childbearing Potential with EpilepsyEvaluation or Interview for Risk of Opioid MisuseFalls: Plan of CareFalls: Risk AssessmentFalls: Screening for Future Fall RiskFollow-Up After Hospitalization for Mental Illness (FUH)Functional Outcome AssessmentFunctional Status Assessment for Total Hip ReplacementFunctional Status Assessment for Total Knee ReplacementFunctional Status Assessments for Congestive Heart FailureFunctional Status Change for Patients with Elbow, Wrist or Hand ImpairmentsFunctional Status Change for Patients with Foot or Ankle ImpairmentsFunctional Status Change for Patients with General Orthopaedic ImpairmentsFunctional Status Change for Patients with Hip ImpairmentsFunctional Status Change for Patients with Knee ImpairmentsFunctional Status Change for Patients with Lumbar ImpairmentsFunctional Status Change for Patients with Shoulder ImpairmentsHeart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow CytometryHematology: Multiple Myeloma: Treatment with BisphosphonatesHematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone MarrowHematology: Myelodysplastic Syndrome (MDS): Documentation of Iron Stores in Patients Receiving Erythropoietin TherapyHepatitis C: Discussion and Shared Decision Making Surrounding Treatment OptionsHepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with CirrhosisHER2 Negative or Undocumented Breast Cancer Patients Spared Treatment with HER2-Targeted TherapiesHIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) ProphylaxisHIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and SyphilisHIV Medical Visit FrequencyHIV Viral Load SuppressionHRS-12: Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation AblationHRS-3: Implantable Cardioverter-Defibrillator (ICD) Complications RateHRS-9: Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or RevisionHypertension: Improvement in Blood PressureImage Confirmation of Successful Excision of Image-Localized Breast LesionImmunizations for AdolescentsInflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) TherapyInflammatory Bowel Disease (IBD): Preventive Care: Corticosteroid Related Iatrogenic Injury - Bone Loss AssessmentInitiation and Engagement of Alcohol and Other Drug Dependence TreatmentIschemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)Ischemic Vascular Disease (IVD): Use of Aspirin or Another AntiplateletKRAS Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody TherapyLung Cancer Reporting (Biopsy/Cytology Specimens)Lung Cancer Reporting (Resection Specimens)Maternal Depression ScreeningMaternity Care: Elective Delivery or Early Induction Without Medical Indication at >= 37 and < 39 Weeks (Overuse)Maternity Care: Post-Partum Follow-Up and Care CoordinationMedication Management for People with AsthmaMedication Reconciliation Post-DischargeMelanoma: Continuity of Care - Recall SystemMelanoma: Coordination of CareMelanoma: Overutilization of Imaging Studies in MelanomaMelanoma ReportingNon-Recommended Cervical Cancer Screening in Adolescent FemalesNuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone ScintigraphyOncology: Medical and Radiation - Pain Intensity QuantifiedOncology: Medical and Radiation - Plan of Care for PainOncology: Radiation Dose Limits to Normal TissuesOne-Time Screening for Hepatitis C Virus (HCV) for Patients at RiskOperative Mortality Stratified by the Five STS-EACTS Mortality CategoriesOpioid Therapy Follow-up EvaluationOptimal Asthma ControlOptimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended GuidelinesOptimizing Patient Exposure to Ionizing Radiation: Computed Tomography (CT) Images Available for Patient Follow-up and Comparison PurposesOptimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine StudiesOptimizing Patient Exposure to Ionizing Radiation: Reporting to a Radiation Dose Index RegistryOptimizing Patient Exposure to Ionizing Radiation: Search for Prior Computed Tomography (CT) Studies Through a Secure, Authorized, Media-Free, Shared ArchiveOptimizing Patient Exposure to Ionizing Radiation: Utilization of a Standardized Nomenclature for Computed Tomography (CT) Imaging DescriptionOsteoarthritis (OA): Function and Pain AssessmentOsteoporosis Management in Women Who Had a FractureOveruse Of Neuroimaging For Patients With Primary Headache And A Normal Neurological ExaminationPain Assessment and Follow-UpPain Brought Under Control Within 48 HoursParkinson's Disease: Cognitive Impairment or Dysfunction AssessmentParkinson's Disease: Parkinson's Disease Medical and Surgical Treatment Options ReviewedParkinson's Disease: Psychiatric Symptoms Assessment for Patients with Parkinson's DiseaseParkinson's Disease: Rehabilitative Therapy OptionsPatient-Centered Surgical Risk Assessment and CommunicationPatients with Metastatic Colorectal Cancer and KRAS Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal AntibodiesPediatric Kidney Disease: Adequacy of Volume Management

Pediatric Kidney Disease: ESRD Patients Receiving Dialysis: Hemoglobin Level < 10 g/dLPelvic Organ Prolapse: Preoperative Assessment of Occult Stress Urinary IncontinencePelvic Organ Prolapse: Preoperative Screening for Uterine MalignancyPerforming Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract InjuryPerioperative Anti-platelet Therapy for Patients Undergoing Carotid EndarterectomyPerioperative Care: Selection of Prophylactic Antibiotic - First OR Second Generation CephalosporinPerioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)Perioperative Temperature ManagementPersistence of Beta-Blocker Treatment After a Heart AttackPhotodocumentation of Cecal IntubationPneumococcal Vaccination Status for Older AdultsPost-Anesthetic Transfer of Care Measure: Procedure Room to a Post Anesthesia Care Unit (PACU)Post-Anesthetic Transfer of Care: Use of Checklist or Protocol for Direct Transfer of Care from Procedure Room to Intensive CareUnit (ICU)Pregnant women that had HBsAg testingPreoperative Diagnosis of Breast CancerPrevention of Central Venous Catheter (CVC) - Related Bloodstream InfectionsPrevention of Post-Operative Nausea and Vomiting (PONV) - Combination TherapyPreventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up PlanPreventive Care and Screening: Influenza ImmunizationPreventive Care and Screening: Screening for Clinical Depression and Follow-Up PlanPreventive Care and Screening: Screening for High Blood Pressure and Follow-Up DocumentedPreventive Care and Screening: Tobacco Use: Screening and Cessation InterventionPreventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief CounselingPrimary Caries Prevention Intervention as Offered by Primary Care Providers, including DentistsPrimary Open-Angle Glaucoma (POAG): Optic Nerve EvaluationPrimary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of CareProportion Admitted to Hospice for less than 3 daysProportion Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of LifeProportion Not Admitted To HospiceProportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse RepairProportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse RepairProportion of Patients Sustaining a Ureter Injury at the Time of any Pelvic Organ Prolapse RepairProportion of Patients who Died from Cancer with more than One Emergency Department Visit in the Last 30 Days of LifeProportion Receiving Chemotherapy in the Last 14 Days of LifeProstate Cancer: Adjuvant Hormonal Therapy for High Risk or Very High Risk Prostate CancerProstate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer PatientsPsoriasis: Clinical Response to Oral Systemic or Biologic MedicationsQuality of Life Assessment For Patients With Primary Headache DisordersQuantitative Immunohistochemical (IHC) Evaluation of Human Epidermal Growth Factor Receptor 2 Testing (HER2) for Breast Cancer PatientsRadiation Consideration for Adult CT: Utilization of Dose Lowering TechniquesRadical Prostatectomy Pathology ReportingRadiology: Exposure Dose or Time Reported for Procedures Using FluoroscopyRadiology: Inappropriate Use of Probably Benign" Assessment Category in Screening Mammograms"Radiology: Reminder System for Screening MammogramsRadiology: Stenosis Measurement in Carotid Imaging ReportsRate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2)Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2)Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) Who Die While in HospitalRate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post Operative Day #2)Rate of Open Repair of Small or Moderate Abdominal Aortic Aneurysms (AAA) Where Patients Are Discharged AliveRate of Open Repair of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7)Rate of Postoperative Stroke or Death in Asymptomatic Patients Undergoing Carotid Artery Stenting (CAS)Rate of Postoperative Stroke or Death in Asymptomatic Patients Undergoing Carotid Endarterectomy (CEA)Rate of Surgical Conversion from Lower Extremity Endovascular Revascularization ProcedureReferral for Otologic Evaluation for Patients with Acute or Chronic DizzinessRheumatoid Arthritis (RA): Assessment and Classification of Disease PrognosisRheumatoid Arthritis (RA): Functional Status AssessmentRheumatoid Arthritis (RA): Glucocorticoid ManagementRheumatoid Arthritis (RA): Periodic Assessment of Disease ActivityRheumatoid Arthritis (RA): Tuberculosis ScreeningRh Immunoglobulin (Rhogam) for Rh-Negative Pregnant Women at Risk of Fetal Blood ExposureRisk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)Screening Colonoscopy Adenoma Detection RateScreening for Osteoporosis for Women Aged 65-85 Years of AgeSentinel Lymph Node Biopsy for Invasive Breast CancerSleep Apnea: Assessment of Adherence to Positive Airway Pressure TherapySleep Apnea: Assessment of Sleep SymptomsSleep Apnea: Positive Airway Pressure Therapy PrescribedSleep Apnea: Severity Assessment at Initial DiagnosisStatin Therapy at Discharge after Lower Extremity Bypass (LEB)Statin Therapy for the Prevention and Treatment of Cardiovascular DiseaseStroke and Stroke Rehabilitation: Discharged on Antithrombotic TherapyStroke and Stroke Rehabilitation: Thrombolytic TherapySurgical Site Infection (SSI)Tobacco Use and Help with Quitting Among AdolescentsTotal Knee Replacement: Identification of Implanted Prosthesis in Operative ReportTotal Knee Replacement: Preoperative Antibiotic Infusion with Proximal TourniquetTotal Knee Replacement: Shared Decision-Making: Trial of Conservative (Non-surgical) TherapyTotal Knee Replacement: Venous Thromboembolic and Cardiovascular Risk EvaluationTrastuzumab Received By Patients With AJCC Stage I (T1c) - III And HER2 Positive Breast Cancer Receiving Adjuvant ChemotherapyTuberculosis (TB) Prevention for Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis Patients on a Biological Immune Response ModifierUltrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal PainUnplanned Hospital Readmission within 30 Days of Principal ProcedureUnplanned Reoperation within the 30 Day Postoperative PeriodUrinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and OlderUrinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and OlderUse of High-Risk Medications in the ElderlyUse of Imaging Studies for Low Back PainVaricose Vein Treatment with Saphenous Ablation: Outcome SurveyWeight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents

271 measures

Optimal Asthma Control

1Childhood Immunization

Status

2

Tobacco Use: Screening and Cessation Intervention

3

Breast Cancer Screening

4

Falls: Risk Assessment

5Use of Imaging Studies for Low

Back Pain

6

15

Advancing CareInformation –

Measuring the use of secure technology helping to engage your patients

16

Option 1 Option 2

ACI Reporting

Clinical Data Registry ReportingClinical Information ReconciliationElectronic Case Reportinge-PrescribingImmunization Registry ReportingPatient-Generated Health DataPatient-Specific EducationProvide Patient AccessPublic Health Registry ReportingSecure MessagingSecurity Risk AnalysisSend a Summary of Care RecordSummary of Care MeasureSyndromic Surveillance ReportingView, Download and Transmit (VDT)

e-PrescribingHealth Information ExchangeImmunization Registry ReportingMedication ReconciliationPatient-Specific EducationProvide Patient AccessSecure MessagingSecurity Risk AnalysisSpecialized Registry ReportingSyndromic Surveillance ReportingView, Download, or Transmit (VDT)

15 Measures

2017-specific

11 Measures

5required

4required

Dependent upon the certification of your EHR

Base ScoreMeasured with a

Yes/No metric

Performance ScoreMeasured on a

0 – 100 scale

Bonus ScoreMeasured on a

0 or 10 basis

50 total points

90 total points

15 total points

155 possible total points,

capped at 100

17

13 clinician practice

Dr. Samuel

Option 2

4 Requiredmeasures for base score

Health Information Exchange

Security Risk Analysis

e-Prescribing

Provide Patient Access

View, Download, or Transmit (VDT)

Patient-Specific Education

Secure Messaging

Syndromic Surveillance Reporting

Medication Reconciliation

Immunization Registry Reporting

Specialized Registry Reporting

7 Optionalmeasures for

additional performance

score

AutoBase Points

50

Health Information Exchange

Provide Patient Access

Total Performance Base Points

21

Syndromic Surveillance Reporting

Specialized Registry Reporting

Total Performance Score Points

18

Total Bonus Points

5

AutoBase Points

50

Total Performance Base Points

21

Total Performance Score Points

18

Total Bonus Points

5

Total ACI points = 94Capped at 100 if higher

Historically, our clients perform better

2015 Meaningful Use Stage 2 attestation

% of HCPs avoidingPQRS penalties in 2016

NATIONAL AVERAGE

60%ATHENAHEALTH

CLIENTS

95.6%NATIONAL AVERAGE

53%ATHENAHEALTH

CLIENTS

97.6%

19

ImprovementActivities –

Measuring and ensuring your proactive management of patient care

20

High Weight Medium Weight

93 possible activities

79 Activities10 points

each

14 Activities20 points

each

Maximum credit

40 points

21

13 clinician practice

Dr. Samuel

High Weight Medium Weight

Medium Weight

Anticoagulant management improvements

Use of Patient Safety Tools

Regular Training in Care Coordination

Total IA points = 40

1

2

3

Currently estimating our clients’ performance in real-time

23

4,752employees

8locations

5services

Specialized teams across the country have your back.

24

Cost – Used to help lower healthcare spending without sacrificing quality

25

Auto calculated by CMS in 2017

Individual(Medicare spending per beneficiary – MSPB)

Group(Total per capita costs for all attributed beneficiaries)

Specific Conditions(episode-based measures)

26

0%of total score

2017

Cost performance category will weigh more in relation to the MIPS final score in subsequent years

2018 2019

10%of total score

30%of total score

27

Calculating a MIPS Final Score

Quality points=

43.2ACI points

=94 IA points

=40

60%

15%

25%

28

15

Quality

ACI

IA

43.2

23.581.7

MIPS Final Score

29

MIPS

CPC+

MU3

PCMH

PCSP

HEDIS measures

Bundled Payments

Industry change is a constant

30

99K+ providers

13%of Americans seen

by athenahealth providers last year

150Ktotal network endpoints

317KMDs served on

Epocrates

9,910 lab and imaging endpoints

VISION: To build an information backbone that helps healthcare work as it should.

140 MDP partners

contracted 2.8Mcovered lives

athenaCollector

Revenue cycle management

athenaClinicals

Medical record

management

EpocratesMedical

reference

athenaCommunicator

Patient engagement

Population Health

Care coordination and risk

management

athenaCoordinator

Network connectivity

a t h e n a O n e

With an integratedsuite of services

Thank You!Questions?